According to Benitec Biopharma 's latest financial reports the company's current EPS (TTM) is -$24.65. In 2022 the company made an earnings per share (EPS) of -$28.73 an increase over its 2021 EPS that were of -$42.84.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$24.65 | -14.2% |
2022 | -$28.73 | -32.93% |
2021 | -$42.84 | -68.14% |
2020 | -$134.47 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -$0.06000 | -99.76% | Bahamas |
NRC Health
NRC | $1.19 | -104.83% | ๐บ๐ธ USA |